OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
853
Results
Show all
Save search
Copy query
Show results for
Unknown
(702)
Transcriptomics
(89)
Genomics
(38)
Proteomics
(19)
Metabolomics
(3)
Genomic
(2)
Organisms
Homo sapiens
(63)
Mus musculus
(29)
Saccharomyces cerevisiae
(9)
Colinus virginianus
(8)
Fundulus grandis
(2)
Sus scrofa
(2)
Shigella flexneri
(2)
Cynoglossus semilaevis
(1)
Trichinella spiralis
(1)
Acropora formosa
(1)
Hypomesus transpacificus
(1)
human gut metagenome
(1)
Tetraodon nigroviridis
(1)
Bombyx mori
(1)
Daphnia magna
(1)
Apis mellifera
(1)
Zea mays
(1)
Oryza sativa
(1)
Bos taurus
(1)
Escherichia coli
(1)
Gallus gallus
(1)
cellular organisms
(1)
Pseudomonas putida KT2440
(1)
Shigella
(1)
Organisms
Mus musculus
(5)
Eschrichtius robustus
(3)
Homo sapiens
(1)
Repository
biostudies-arrayexpress
(97)
EGA
(18)
ENA
(12)
pride
(11)
MassIVE
(5)
MetaboLights
(3)
dbGaP
(2)
iProX
(1)
jPOST
(1)
PanoramaPublic
(1)
Tissue
Cell culture
(4)
Blood plasma
(2)
Breast
(1)
Cell suspension culture
(1)
Early embryonic cell
(1)
Epithelial cell
(1)
Fibroblast
(1)
Saliva
(1)
T cell
(1)
Urine
(1)
Disease
Neuroblastoma
(1)
Breast cancer
(1)
Prostate adenocarcinoma
(1)
Technology Type
Mass Spectrometry
(11)
Illumina 15K
(8)
Shotgun proteomics
(8)
Mass spectrometry
(3)
Affinity purification coupled with mass spectrometry proteomics
(2)
Affymetrix 6.0
(1)
Illumina 1.2M, Affymetrix 6.0
(1)
Bottom-up proteomics
(1)
Data-independent acquisition
(1)
SWATH MS
(1)
Instrument Platform
NextSeq 500
(3)
NextSeq 550
(2)
DNA Microarray Scanner (Model G2505C, Agilent Technologies)
(1)
NextSeq 2000
(1)
Illumina MiSeq
(1)
Illumina NovaSeq 6000
(1)
Illumina HiSeq 2000
(1)
Orbitrap Exploris 480
(1)
Orbitrap Fusion
(1)
Orbitrap Fusion Lumos
(1)
Q Exactive HF
(1)
Q Exactive HF-X
(1)
TimsTOF Pro
(1)
API 4000 QTRAP (AB Sciex)
(1)
Agilent 5975E GC/MSD (Agilent)
(1)
Liquid Chromatography MS - negative - reverse phase
(1)
Liquid Chromatography MS - positive - direct infusion
(1)
Liquid Chromatography MS - positive - reverse phase
(1)
TSQ Quantum XLS (Thermo Scientific)
(1)
Publication Date
2011
(19)
2014
(17)
2016
(10)
2010
(9)
2012
(8)
2020
(7)
2023
(7)
2013
(6)
2019
(5)
2026
(4)
2022
(4)
2015
(4)
2009
(4)
2017
(3)
2006
(3)
2007
(2)
2005
(2)
2024
(2)
2025
(1)
2018
(1)
2021
(1)
CHEBI ID
CHEBI:10022
(1)
CHEBI:12962
(1)
CHEBI:133365
(1)
CHEBI:136236
(1)
CHEBI:136239
(1)
CHEBI:136245
(1)
CHEBI:136570
(1)
CHEBI:136664
(1)
CHEBI:136665
(1)
CHEBI:136666
(1)
CHEBI:136667
(1)
CHEBI:136676
(1)
CHEBI:136678
(1)
CHEBI:136680
(1)
CHEBI:136681
(1)
CHEBI:140361
(1)
CHEBI:140362
(1)
CHEBI:14314
(1)
CHEBI:149442
(1)
CHEBI:149447
(1)
CHEBI:149449
(1)
CHEBI:149450
(1)
CHEBI:149452
(1)
CHEBI:149454
(1)
CHEBI:149456
(1)
CHEBI:149457
(1)
CHEBI:149459
(1)
CHEBI:149460
(1)
CHEBI:15333
(1)
CHEBI:15354
(1)
Metabolite Name
(6R)-5,6,7,8-Tetrahydrobiopterin
(1)
1,3-Diaminopropane.HCl
(1)
1,4-Diaminobutane
(1)
1-Kestose
(1)
1-Methylguanidine
(1)
1-Methylhistamine.HCl
(1)
1-Methylhistidine
(1)
1-Methylnicotinamide.HCl
(1)
1-Octacosanol
(1)
1-aminocyclopropanecarboxylic acid
(1)
2,3-Dihydroxybenzoic Acid
(1)
2,3-Pyridinedicarboxylic acid
(1)
2,4-dihydroxyacetophenone
(1)
2-Deoxyadenosine-5-Monophosphate
(1)
2-Deoxyadenosine.H2O
(1)
2-Deoxyguanosine
(1)
2-Deoxyguanosine-5-Monphosphate
(1)
2-Deoxyinosine
(1)
2-Deoxyinosine-5-Triphosphate
(1)
2-Deoxyribose-5-phosphate Na salt
(1)
2-Guanidinopropionic acid
(1)
2-Hydroxy-4-methoxyacetophenone
(1)
2-Hydroxycinnamic acid
(1)
2-Hydroxyisobutyric acid
(1)
2-Hydroxyphenylacetic acid
(1)
2-Hydroxypyridine
(1)
2-Isopropylmalic acid
(1)
2-aminoethylphosphonic acid
(1)
3,4-Dihydroxyphenyl acetic acid
(1)
3,4-Dihydroxyphenyl alanine
(1)
First Public Date
2024
(7)
2023
(3)
2020
(1)
2016
(1)
Study type
Transcription profiling by array
(66)
RNA-seq of coding RNA
(13)
ChIP-seq
(5)
Transcription profiling by SAGE
(3)
Methylation profiling by high throughput sequencing
(3)
MicroRNA profiling by array
(2)
Animal - High-throughput sequencing
(1)
Capture-C
(1)
Other
(1)
RNA-seq of coding RNA from single cells
(1)
RNA-seq of non coding RNA
(1)
Release Date
2021
(79)
2024
(70)
2025
(69)
2020
(66)
2019
(63)
2022
(62)
2023
(62)
2016
(46)
2014
(45)
2018
(43)
2017
(42)
2011
(30)
2015
(27)
2013
(24)
2012
(21)
2010
(18)
2009
(11)
2026
(7)
2007
(4)
2006
(3)
2008
(3)
2005
(2)
2002
(1)
1998
(1)
Lab affiliation
Pacific Northwest National Laboratory
(4)
Advanced Technology Walter & ELiza Hall Institute
(1)
Department of Chemistry and School of Pharmacy, University of Wisconsin-Madison
(1)
Laboratory Head and Chemical Biology Division Head, WEHI, Australia
(1)
Laboratory of Vaccines for the Developing World, Institute for Glycomics, Southport, QLD, Australia
(1)
Nottingham Trent University, John van Geest Cancer Research Centre.
(1)
VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium. Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
(1)
VIB-UGent Center for Medical Biotechnology, VIB, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium. UGent Department of Biomolecular Medicine, Ghent University, Technologiepark-Zwijnaarde, 9052 Ghent, Belgium.
(1)
Tags
xref:PubMed:26730594
(5)
xref:PubMed:31211793
(5)
xref:PubMed:32661178
(1)
xref:PubMed:33911273
(1)
Previous
page
1 / 86
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
86
Next
page
Sort
by:
Relevance
Page size
10
Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial.
Not available
S-EPMC3804556
|
biostudies-literature
Cite
Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.
The goal of this project was to characterize changes in gene expression in response to the anti-cancer agent sapphyrin PCI-2050. Cultured A549 human lung cancer cells were treated with sapphyrin PCI-2050 or actinomycin D.
ORGANISM(S):
Homo sapiens
2007-10-26
|
E-GEOD-6400
|
biostudies-arrayexpress
Cite
Antitarget Selectivity and Tolerability of Novel Pyrrolo[2,3-
d
]pyrimidine RET Inhibitors.
Not available
S-EPMC8667305
|
biostudies-literature
Cite
Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis.
Not available
S-EPMC7394189
|
biostudies-literature
Cite
Optimization of Drug Candidates That Inhibit the D-Loop Activity of RAD51.
Not available
S-EPMC6525040
|
biostudies-literature
Cite
Improving the Patient Experience With Migraine Camp, a One-Day Group Intervention for Adolescents With Chronic Headache and Their Parents.
Not available
S-EPMC7316641
|
biostudies-literature
Cite
Vitamin D levels in children with attention deficit hyperactivity disorder: Association with seasonal and geographical variation, supplementation, inattention severity, and theta:beta ratio.
Not available
S-EPMC8187333
|
biostudies-literature
Cite
Identification of 6-amino-1
H
-pyrazolo[3,4-
d
]pyrimidines with
in vivo
efficacy against visceral leishmaniasis.
Not available
S-EPMC7651859
|
biostudies-literature
Cite
Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression
Not available
ORGANISM(S):
Homo sapiens
S-ECPF-GEOD-6400
|
biostudies-other
Cite
Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease.
Not available
S-EPMC3167813
|
biostudies-literature
Cite
Previous
page
1 / 86
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
86
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
